EvolutionMedicine

A study by Guo and Yang was just published comparing two kidney treatment strategies for patients with sepsis and acute kidney injury: In the first group, patients with kidney failure due to sepsis received early renal replacement therapy.

Should we block inflammation or boost it?

Proton pump inhibitors are drugs that block the hydrogen/potassium ATP-ase enzyme responsible for the secretion of stomach acid.

Why does the immune system over-react and sometimes kill us?

I have been thinking a lot over the last decade about what features of the microbiota really matter.

Over evolutionary time, organisms have had to evolve ways to cope with varying oxygen levels.

Humans and other animals have evolved adaptations to hypoxia, most famously among high altitude people.

Is it normal to be hypoxic in the earliest stages of life?

Posing “why” questions is a classic approach in evolutionary medicine.

My colleagues and I had another paper published last week.

Thymosin α1 is an immune modulating drug that was recently the subject of a large scale multi-center randomized clinical trial in China.